Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Von Hippel-Lindau Tumor Suppressor Protein | 75 | 2023 | 290 | 8.830 |
Why?
|
von Hippel-Lindau Disease | 38 | 2022 | 153 | 6.920 |
Why?
|
Carcinoma, Renal Cell | 48 | 2023 | 3101 | 4.560 |
Why?
|
Ubiquitin-Protein Ligases | 50 | 2018 | 1849 | 4.490 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 23 | 2022 | 1116 | 4.370 |
Why?
|
Kidney Neoplasms | 49 | 2023 | 4189 | 4.320 |
Why?
|
Ligases | 37 | 2022 | 332 | 4.240 |
Why?
|
Genes, Tumor Suppressor | 44 | 2018 | 1096 | 4.060 |
Why?
|
Tumor Suppressor Proteins | 66 | 2016 | 2845 | 4.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 36 | 2023 | 628 | 3.510 |
Why?
|
Procollagen-Proline Dioxygenase | 16 | 2013 | 86 | 3.230 |
Why?
|
Retinoblastoma Protein | 31 | 2018 | 700 | 2.880 |
Why?
|
Oxygen | 25 | 2022 | 4158 | 2.760 |
Why?
|
Hypoxia-Inducible Factor 1 | 22 | 2019 | 198 | 2.450 |
Why?
|
Nuclear Proteins | 39 | 2019 | 5830 | 2.320 |
Why?
|
DNA-Binding Proteins | 61 | 2018 | 9622 | 2.270 |
Why?
|
Transcription Factors | 78 | 2023 | 12120 | 2.210 |
Why?
|
Dioxygenases | 9 | 2020 | 316 | 1.890 |
Why?
|
Cell Cycle Proteins | 40 | 2015 | 3433 | 1.780 |
Why?
|
Ketoglutaric Acids | 4 | 2020 | 78 | 1.760 |
Why?
|
Indans | 4 | 2022 | 96 | 1.680 |
Why?
|
Glutarates | 6 | 2018 | 235 | 1.530 |
Why?
|
Proteins | 32 | 2022 | 6082 | 1.520 |
Why?
|
Sulfones | 4 | 2022 | 436 | 1.440 |
Why?
|
Neoplasms | 44 | 2020 | 21507 | 1.430 |
Why?
|
Gene Expression Regulation, Neoplastic | 31 | 2022 | 8400 | 1.330 |
Why?
|
Tumor Suppressor Protein p53 | 20 | 2022 | 2948 | 1.300 |
Why?
|
Proline | 10 | 2023 | 454 | 1.170 |
Why?
|
Small Cell Lung Carcinoma | 3 | 2019 | 384 | 1.110 |
Why?
|
Carrier Proteins | 29 | 2001 | 5012 | 1.100 |
Why?
|
Thalidomide | 4 | 2022 | 878 | 1.070 |
Why?
|
Isocitrate Dehydrogenase | 9 | 2023 | 869 | 1.060 |
Why?
|
Cullin Proteins | 8 | 2003 | 180 | 1.040 |
Why?
|
Cell Transformation, Neoplastic | 11 | 2019 | 2936 | 1.040 |
Why?
|
Kynurenic Acid | 2 | 2022 | 45 | 1.010 |
Why?
|
Cell Cycle | 26 | 2008 | 2960 | 0.980 |
Why?
|
Trans-Activators | 15 | 2019 | 2922 | 0.980 |
Why?
|
Pheochromocytoma | 11 | 2019 | 337 | 0.970 |
Why?
|
Indigofera | 1 | 2023 | 2 | 0.960 |
Why?
|
Animals | 140 | 2022 | 168368 | 0.920 |
Why?
|
Cell Hypoxia | 16 | 2020 | 676 | 0.920 |
Why?
|
RNA, Small Interfering | 15 | 2022 | 3498 | 0.880 |
Why?
|
Ubiquitins | 11 | 2022 | 382 | 0.860 |
Why?
|
Retinoblastoma-Binding Protein 2 | 3 | 2019 | 31 | 0.860 |
Why?
|
Vascular Endothelial Growth Factor A | 11 | 2022 | 3504 | 0.830 |
Why?
|
Antineoplastic Agents | 18 | 2020 | 13635 | 0.830 |
Why?
|
Glioma | 7 | 2023 | 3378 | 0.810 |
Why?
|
Adrenal Gland Neoplasms | 8 | 2021 | 735 | 0.810 |
Why?
|
SKP Cullin F-Box Protein Ligases | 5 | 2015 | 177 | 0.800 |
Why?
|
CDC2-CDC28 Kinases | 5 | 2004 | 113 | 0.790 |
Why?
|
Mutation | 54 | 2023 | 29658 | 0.790 |
Why?
|
Transcription, Genetic | 28 | 2019 | 7709 | 0.790 |
Why?
|
Repressor Proteins | 11 | 2015 | 3007 | 0.790 |
Why?
|
Mice | 84 | 2022 | 81002 | 0.780 |
Why?
|
Genes, p53 | 8 | 2003 | 752 | 0.780 |
Why?
|
Erythropoietin | 3 | 2012 | 724 | 0.770 |
Why?
|
Ikaros Transcription Factor | 3 | 2021 | 213 | 0.760 |
Why?
|
Mitochondria, Heart | 1 | 2022 | 248 | 0.760 |
Why?
|
F-Box Proteins | 3 | 2015 | 197 | 0.750 |
Why?
|
Molecular Targeted Therapy | 5 | 2020 | 2727 | 0.750 |
Why?
|
Paraganglioma | 4 | 2021 | 144 | 0.740 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 2 | 2019 | 182 | 0.740 |
Why?
|
Hydroxylation | 15 | 2023 | 142 | 0.730 |
Why?
|
Histone Demethylases | 3 | 2019 | 311 | 0.730 |
Why?
|
Hemangioblastoma | 6 | 2010 | 70 | 0.680 |
Why?
|
E2F Transcription Factors | 26 | 2003 | 273 | 0.680 |
Why?
|
Neuroendocrine Cells | 1 | 2019 | 61 | 0.670 |
Why?
|
Quinazolines | 3 | 2021 | 1356 | 0.670 |
Why?
|
Cell Line, Tumor | 28 | 2022 | 16646 | 0.660 |
Why?
|
Retinoblastoma-Binding Protein 1 | 24 | 2000 | 142 | 0.650 |
Why?
|
Signal Transduction | 23 | 2021 | 23355 | 0.650 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2018 | 97 | 0.640 |
Why?
|
Humans | 213 | 2023 | 739398 | 0.620 |
Why?
|
RNA Interference | 8 | 2020 | 2899 | 0.620 |
Why?
|
Molecular Sequence Data | 41 | 2015 | 18125 | 0.620 |
Why?
|
Transaminases | 1 | 2018 | 201 | 0.620 |
Why?
|
Genes, Retinoblastoma | 5 | 2018 | 136 | 0.620 |
Why?
|
Transcription Factor DP1 | 23 | 2000 | 141 | 0.620 |
Why?
|
Peptides | 4 | 2019 | 4395 | 0.610 |
Why?
|
Mice, Nude | 16 | 2019 | 3692 | 0.610 |
Why?
|
Citric Acid Cycle | 5 | 2020 | 230 | 0.600 |
Why?
|
Tumor Cells, Cultured | 31 | 2018 | 6310 | 0.600 |
Why?
|
Ubiquitination | 4 | 2020 | 1003 | 0.600 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2019 | 322 | 0.600 |
Why?
|
Oncogene Proteins, Viral | 8 | 2000 | 362 | 0.600 |
Why?
|
Humanities | 1 | 2017 | 52 | 0.600 |
Why?
|
Histone Code | 1 | 2018 | 162 | 0.590 |
Why?
|
Fumarate Hydratase | 2 | 2014 | 45 | 0.590 |
Why?
|
Transcriptional Activation | 13 | 2010 | 1783 | 0.590 |
Why?
|
Polycythemia | 4 | 2021 | 126 | 0.590 |
Why?
|
Cyclin-Dependent Kinases | 7 | 2019 | 670 | 0.590 |
Why?
|
Mammals | 3 | 2012 | 1112 | 0.580 |
Why?
|
Immediate-Early Proteins | 4 | 2008 | 453 | 0.570 |
Why?
|
Apoptosis | 22 | 2022 | 9714 | 0.570 |
Why?
|
Oncogene Proteins | 1 | 2021 | 750 | 0.570 |
Why?
|
Research Report | 1 | 2019 | 351 | 0.560 |
Why?
|
Famous Persons | 1 | 2017 | 108 | 0.560 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2019 | 528 | 0.550 |
Why?
|
Phosphoproteins | 8 | 2002 | 2440 | 0.550 |
Why?
|
Neoplasm Proteins | 4 | 2018 | 3694 | 0.550 |
Why?
|
Base Sequence | 30 | 2017 | 12804 | 0.540 |
Why?
|
Glutamic Acid | 2 | 2018 | 1168 | 0.530 |
Why?
|
G1 Phase | 10 | 2020 | 414 | 0.530 |
Why?
|
Ischemic Preconditioning | 1 | 2016 | 92 | 0.530 |
Why?
|
S-Phase Kinase-Associated Proteins | 6 | 2020 | 90 | 0.520 |
Why?
|
Amino Acid Sequence | 28 | 2017 | 13816 | 0.520 |
Why?
|
Proto-Oncogene Proteins c-abl | 2 | 2014 | 146 | 0.520 |
Why?
|
Cell Physiological Phenomena | 1 | 2016 | 154 | 0.520 |
Why?
|
Congresses as Topic | 1 | 2019 | 760 | 0.510 |
Why?
|
Cell Line | 29 | 2020 | 15987 | 0.510 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2022 | 1214 | 0.510 |
Why?
|
Receptors, Notch | 1 | 2019 | 737 | 0.500 |
Why?
|
Luciferases | 5 | 2005 | 734 | 0.500 |
Why?
|
Metabolic Networks and Pathways | 4 | 2019 | 781 | 0.500 |
Why?
|
Paracrine Communication | 1 | 2016 | 276 | 0.500 |
Why?
|
Cyclins | 6 | 1999 | 601 | 0.500 |
Why?
|
Science | 1 | 2017 | 241 | 0.500 |
Why?
|
Protein Binding | 33 | 2015 | 9375 | 0.490 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2014 | 67 | 0.490 |
Why?
|
Cell Proliferation | 10 | 2018 | 10455 | 0.470 |
Why?
|
Gene Expression Regulation | 21 | 2017 | 12049 | 0.460 |
Why?
|
Teratogens | 1 | 2013 | 113 | 0.450 |
Why?
|
Ubiquitin-Protein Ligase Complexes | 3 | 2019 | 168 | 0.450 |
Why?
|
Cyclin-Dependent Kinase 2 | 6 | 2005 | 191 | 0.440 |
Why?
|
Cell Differentiation | 9 | 2019 | 11460 | 0.420 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2013 | 404 | 0.420 |
Why?
|
Gene Dosage | 3 | 2013 | 1251 | 0.420 |
Why?
|
Metabolism | 2 | 2013 | 192 | 0.420 |
Why?
|
Feedback, Physiological | 2 | 2017 | 478 | 0.410 |
Why?
|
Climate Change | 1 | 2017 | 411 | 0.410 |
Why?
|
Adaptor Proteins, Signal Transducing | 5 | 2021 | 2910 | 0.410 |
Why?
|
Enzyme Inhibitors | 7 | 2022 | 3802 | 0.410 |
Why?
|
Binding Sites | 23 | 2014 | 6113 | 0.410 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2017 | 1374 | 0.400 |
Why?
|
Cysteine | 1 | 2016 | 870 | 0.400 |
Why?
|
src-Family Kinases | 1 | 2014 | 549 | 0.400 |
Why?
|
Myocardial Ischemia | 1 | 2022 | 2146 | 0.400 |
Why?
|
E2F1 Transcription Factor | 17 | 2003 | 191 | 0.400 |
Why?
|
Recombinant Fusion Proteins | 20 | 2018 | 3770 | 0.390 |
Why?
|
Politics | 1 | 2017 | 782 | 0.390 |
Why?
|
Chromatin | 3 | 2019 | 2848 | 0.380 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2011 | 300 | 0.370 |
Why?
|
Histones | 6 | 2019 | 2591 | 0.370 |
Why?
|
Peptide Hydrolases | 1 | 2013 | 627 | 0.370 |
Why?
|
Myocardial Stunning | 1 | 2010 | 68 | 0.370 |
Why?
|
Mutagenesis, Site-Directed | 9 | 2020 | 1721 | 0.370 |
Why?
|
Leukemia | 2 | 2022 | 1502 | 0.370 |
Why?
|
Adenoma, Oxyphilic | 1 | 2011 | 136 | 0.360 |
Why?
|
Liver | 10 | 2016 | 7449 | 0.360 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2019 | 3562 | 0.360 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2010 | 83 | 0.360 |
Why?
|
Publishing | 1 | 2017 | 828 | 0.350 |
Why?
|
Protein Kinases | 5 | 2004 | 1637 | 0.350 |
Why?
|
CARD Signaling Adaptor Proteins | 2 | 2007 | 150 | 0.350 |
Why?
|
Pituitary Neoplasms | 1 | 2018 | 1334 | 0.350 |
Why?
|
Homeostasis | 3 | 2018 | 3348 | 0.340 |
Why?
|
Transfection | 14 | 2009 | 5884 | 0.340 |
Why?
|
HeLa Cells | 9 | 2015 | 3119 | 0.330 |
Why?
|
Methylation | 5 | 2019 | 1106 | 0.330 |
Why?
|
Protein Processing, Post-Translational | 5 | 2004 | 1991 | 0.330 |
Why?
|
Genes | 2 | 2012 | 1898 | 0.320 |
Why?
|
Integrases | 2 | 2018 | 532 | 0.320 |
Why?
|
Research | 1 | 2017 | 2001 | 0.320 |
Why?
|
Energy Metabolism | 1 | 2019 | 2896 | 0.320 |
Why?
|
Gene Knockdown Techniques | 2 | 2012 | 1654 | 0.320 |
Why?
|
Cell Division | 14 | 2008 | 4575 | 0.320 |
Why?
|
S Phase | 9 | 2020 | 422 | 0.320 |
Why?
|
Health Care Reform | 1 | 2017 | 1258 | 0.320 |
Why?
|
Down-Regulation | 8 | 2009 | 2999 | 0.310 |
Why?
|
Reactive Oxygen Species | 3 | 2020 | 2084 | 0.310 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2017 | 1206 | 0.300 |
Why?
|
Chromosomes, Mammalian | 1 | 2008 | 150 | 0.300 |
Why?
|
Luminescent Measurements | 3 | 2004 | 405 | 0.300 |
Why?
|
Models, Animal | 3 | 2016 | 2164 | 0.300 |
Why?
|
Disease | 1 | 2013 | 683 | 0.300 |
Why?
|
Enzyme Activation | 5 | 2018 | 3701 | 0.300 |
Why?
|
Casein Kinase II | 1 | 2007 | 127 | 0.300 |
Why?
|
Retinol-Binding Proteins | 1 | 2007 | 65 | 0.300 |
Why?
|
Point Mutation | 4 | 2011 | 1626 | 0.290 |
Why?
|
Peptide Synthases | 3 | 2002 | 81 | 0.290 |
Why?
|
Germ-Line Mutation | 6 | 2010 | 1786 | 0.290 |
Why?
|
Models, Biological | 13 | 2016 | 9609 | 0.290 |
Why?
|
Proto-Oncogene Proteins c-jun | 3 | 2011 | 286 | 0.290 |
Why?
|
Endothelial Growth Factors | 4 | 2003 | 695 | 0.280 |
Why?
|
Glycolysis | 3 | 2020 | 825 | 0.280 |
Why?
|
Piperidines | 1 | 2014 | 1597 | 0.280 |
Why?
|
Antigens, Polyomavirus Transforming | 3 | 1992 | 257 | 0.280 |
Why?
|
Plasmids | 8 | 2005 | 2307 | 0.270 |
Why?
|
Research Design | 2 | 2017 | 5959 | 0.270 |
Why?
|
Lymphokines | 4 | 2003 | 950 | 0.270 |
Why?
|
Oncogene Protein p65(gag-jun) | 1 | 2005 | 7 | 0.270 |
Why?
|
Drug Design | 3 | 2007 | 1088 | 0.270 |
Why?
|
Mice, Mutant Strains | 5 | 2011 | 1883 | 0.270 |
Why?
|
Clusterin | 1 | 2006 | 72 | 0.270 |
Why?
|
Genes, Lethal | 2 | 2005 | 243 | 0.270 |
Why?
|
Drugs, Investigational | 1 | 2007 | 215 | 0.260 |
Why?
|
Acetyl-CoA Carboxylase | 2 | 2016 | 78 | 0.260 |
Why?
|
Hydroxyproline | 2 | 2002 | 114 | 0.250 |
Why?
|
Neovascularization, Pathologic | 8 | 2003 | 2639 | 0.250 |
Why?
|
Oncogenes | 4 | 2018 | 1264 | 0.250 |
Why?
|
Succinate Dehydrogenase | 4 | 2010 | 146 | 0.250 |
Why?
|
Multigene Family | 2 | 1999 | 1107 | 0.250 |
Why?
|
Cells, Cultured | 14 | 2014 | 19220 | 0.250 |
Why?
|
Thyroid Neoplasms | 1 | 2018 | 2267 | 0.250 |
Why?
|
Oxidative Stress | 2 | 2019 | 3087 | 0.250 |
Why?
|
Indoles | 2 | 2023 | 1832 | 0.250 |
Why?
|
Peutz-Jeghers Syndrome | 1 | 2004 | 50 | 0.240 |
Why?
|
Mice, Transgenic | 6 | 2012 | 9734 | 0.240 |
Why?
|
Calcium Channels | 1 | 2008 | 621 | 0.240 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2010 | 852 | 0.240 |
Why?
|
Fibroblasts | 7 | 2018 | 4137 | 0.240 |
Why?
|
DNA Primers | 7 | 2005 | 2893 | 0.240 |
Why?
|
HEK293 Cells | 4 | 2019 | 4174 | 0.230 |
Why?
|
Phosphorylation | 11 | 2016 | 8416 | 0.230 |
Why?
|
Erythropoiesis | 4 | 2014 | 703 | 0.230 |
Why?
|
Hematopoiesis | 1 | 2013 | 2049 | 0.230 |
Why?
|
Piperazines | 3 | 2019 | 2480 | 0.230 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2005 | 432 | 0.230 |
Why?
|
Mitochondrial Proteins | 1 | 2009 | 989 | 0.220 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2008 | 862 | 0.220 |
Why?
|
Epigenesis, Genetic | 2 | 2013 | 3614 | 0.220 |
Why?
|
Vascular Endothelial Growth Factors | 5 | 2012 | 773 | 0.220 |
Why?
|
Macromolecular Substances | 9 | 2002 | 1457 | 0.220 |
Why?
|
Neoplasm Transplantation | 4 | 2016 | 2084 | 0.220 |
Why?
|
Receptors, Growth Factor | 2 | 2008 | 334 | 0.220 |
Why?
|
Cyclin A | 2 | 2001 | 60 | 0.210 |
Why?
|
Optic Nerve Neoplasms | 1 | 2002 | 44 | 0.210 |
Why?
|
Hamartoma | 1 | 2004 | 236 | 0.210 |
Why?
|
Recombination, Genetic | 2 | 2006 | 1591 | 0.210 |
Why?
|
Phenotype | 14 | 2014 | 16301 | 0.210 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2023 | 265 | 0.210 |
Why?
|
DNA, Complementary | 4 | 2005 | 2049 | 0.210 |
Why?
|
Central Nervous System Neoplasms | 2 | 2010 | 894 | 0.210 |
Why?
|
Promoter Regions, Genetic | 10 | 2004 | 5863 | 0.210 |
Why?
|
Proto-Oncogene Proteins | 10 | 2015 | 4555 | 0.210 |
Why?
|
Protein Structure, Tertiary | 9 | 2007 | 3848 | 0.210 |
Why?
|
Adenovirus E1A Proteins | 2 | 2000 | 76 | 0.210 |
Why?
|
Reproducibility of Results | 2 | 2017 | 19811 | 0.200 |
Why?
|
Myocytes, Cardiac | 1 | 2010 | 1625 | 0.200 |
Why?
|
Alleles | 7 | 2018 | 6942 | 0.200 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2019 | 5148 | 0.200 |
Why?
|
Adenovirus E4 Proteins | 2 | 2001 | 7 | 0.200 |
Why?
|
Mice, Inbred C57BL | 10 | 2019 | 21863 | 0.200 |
Why?
|
Indenes | 1 | 2021 | 57 | 0.200 |
Why?
|
Genetic Predisposition to Disease | 6 | 2010 | 17384 | 0.200 |
Why?
|
Protein Kinase Inhibitors | 4 | 2019 | 5502 | 0.200 |
Why?
|
PC12 Cells | 3 | 2019 | 330 | 0.190 |
Why?
|
Adenosine Triphosphate | 2 | 2022 | 2022 | 0.190 |
Why?
|
Biology | 1 | 2023 | 292 | 0.190 |
Why?
|
Gene Expression Profiling | 10 | 2019 | 9387 | 0.190 |
Why?
|
Cell Survival | 5 | 2019 | 5877 | 0.190 |
Why?
|
Cyclin E | 1 | 2001 | 172 | 0.190 |
Why?
|
Asparagine | 3 | 2008 | 123 | 0.190 |
Why?
|
Immunoblotting | 5 | 2009 | 1683 | 0.190 |
Why?
|
NF-kappa B | 2 | 2018 | 2502 | 0.190 |
Why?
|
Enzyme Stability | 3 | 2011 | 210 | 0.180 |
Why?
|
PTEN Phosphohydrolase | 2 | 2018 | 1142 | 0.180 |
Why?
|
Cell Respiration | 1 | 2020 | 203 | 0.180 |
Why?
|
E2F4 Transcription Factor | 4 | 2012 | 36 | 0.180 |
Why?
|
Fetal Development | 1 | 2006 | 763 | 0.180 |
Why?
|
Benzylamines | 1 | 2021 | 227 | 0.180 |
Why?
|
Retinol-Binding Proteins, Cellular | 2 | 2011 | 13 | 0.180 |
Why?
|
Drug Delivery Systems | 3 | 2010 | 2220 | 0.170 |
Why?
|
Fibronectins | 6 | 2004 | 723 | 0.170 |
Why?
|
Membrane Proteins | 3 | 2001 | 7862 | 0.170 |
Why?
|
Rabbits | 2 | 2022 | 4882 | 0.170 |
Why?
|
Adaptation, Physiological | 2 | 2017 | 1310 | 0.170 |
Why?
|
Lung Neoplasms | 3 | 2019 | 12985 | 0.170 |
Why?
|
RNA, Untranslated | 2 | 2017 | 452 | 0.170 |
Why?
|
Aminopyridines | 2 | 2019 | 541 | 0.170 |
Why?
|
Retroviridae | 4 | 2008 | 913 | 0.170 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2001 | 207 | 0.170 |
Why?
|
Retinoblastoma | 3 | 1998 | 317 | 0.170 |
Why?
|
Conserved Sequence | 2 | 2007 | 1203 | 0.160 |
Why?
|
Pyrroles | 2 | 2019 | 1142 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 4 | 2010 | 379 | 0.160 |
Why?
|
Optic Disk | 1 | 2002 | 402 | 0.160 |
Why?
|
Disease Models, Animal | 8 | 2019 | 18003 | 0.160 |
Why?
|
DNA | 9 | 2001 | 7275 | 0.160 |
Why?
|
Adenocarcinoma, Clear Cell | 3 | 2004 | 221 | 0.160 |
Why?
|
RNA, Messenger | 9 | 2007 | 13002 | 0.150 |
Why?
|
Ubiquitin | 6 | 2006 | 847 | 0.150 |
Why?
|
Models, Genetic | 4 | 2005 | 3493 | 0.150 |
Why?
|
Gene Deletion | 7 | 2011 | 2757 | 0.150 |
Why?
|
New York City | 1 | 2019 | 704 | 0.150 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2018 | 294 | 0.150 |
Why?
|
Pregnancy Proteins | 1 | 2018 | 229 | 0.150 |
Why?
|
Chromosome Segregation | 1 | 2018 | 236 | 0.150 |
Why?
|
DNA Damage | 4 | 2020 | 2419 | 0.150 |
Why?
|
Mice, Knockout | 9 | 2019 | 14558 | 0.150 |
Why?
|
Extracellular Matrix | 5 | 2004 | 1734 | 0.150 |
Why?
|
Heart Septal Defects | 1 | 2018 | 192 | 0.150 |
Why?
|
Alternative Splicing | 2 | 2018 | 1117 | 0.150 |
Why?
|
Chromosome Mapping | 5 | 2010 | 4743 | 0.140 |
Why?
|
Membrane Glycoproteins | 1 | 2008 | 3768 | 0.140 |
Why?
|
Neuroblastoma | 3 | 2015 | 1214 | 0.140 |
Why?
|
Retinal Neoplasms | 2 | 1999 | 143 | 0.140 |
Why?
|
Cyclin D1 | 3 | 2014 | 462 | 0.140 |
Why?
|
Mass Spectrometry | 3 | 2015 | 2200 | 0.140 |
Why?
|
Recombinant Proteins | 7 | 2017 | 6610 | 0.140 |
Why?
|
Amino Acid Transport System y+ | 1 | 2016 | 35 | 0.140 |
Why?
|
Glutathione | 1 | 2019 | 585 | 0.140 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2005 | 1659 | 0.140 |
Why?
|
Substrate Specificity | 4 | 2018 | 1798 | 0.140 |
Why?
|
Growth Inhibitors | 3 | 1997 | 386 | 0.140 |
Why?
|
Zea mays | 1 | 1996 | 105 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2016 | 2507 | 0.140 |
Why?
|
Parabiosis | 1 | 2016 | 65 | 0.140 |
Why?
|
Tuberous Sclerosis | 1 | 2004 | 1030 | 0.140 |
Why?
|
NF-E2-Related Factor 1 | 1 | 2015 | 23 | 0.140 |
Why?
|
Viral Proteins | 1 | 2003 | 1900 | 0.140 |
Why?
|
DNA Mutational Analysis | 6 | 2019 | 4182 | 0.140 |
Why?
|
Multiple Myeloma | 1 | 2013 | 5147 | 0.130 |
Why?
|
Oxidation-Reduction | 2 | 2018 | 2184 | 0.130 |
Why?
|
Biomarkers, Pharmacological | 1 | 2016 | 163 | 0.130 |
Why?
|
Polyubiquitin | 1 | 2015 | 67 | 0.130 |
Why?
|
3T3 Cells | 6 | 2004 | 1103 | 0.130 |
Why?
|
Genomic Instability | 1 | 2019 | 688 | 0.130 |
Why?
|
Succinic Acid | 1 | 2015 | 82 | 0.130 |
Why?
|
Cloning, Molecular | 7 | 2002 | 4319 | 0.130 |
Why?
|
Pyridines | 2 | 2019 | 2810 | 0.130 |
Why?
|
Forkhead Transcription Factors | 2 | 2014 | 1602 | 0.130 |
Why?
|
Peptide Fragments | 2 | 1999 | 5076 | 0.130 |
Why?
|
Simian virus 40 | 2 | 1998 | 295 | 0.130 |
Why?
|
Fumarates | 1 | 2015 | 133 | 0.130 |
Why?
|
Tumor Burden | 3 | 2019 | 1904 | 0.130 |
Why?
|
Species Specificity | 1 | 2019 | 2480 | 0.130 |
Why?
|
Dimerization | 3 | 2007 | 892 | 0.130 |
Why?
|
Proto-Oncogene Protein c-ets-2 | 1 | 2014 | 16 | 0.130 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 4463 | 0.130 |
Why?
|
Frameshift Mutation | 1 | 2017 | 398 | 0.130 |
Why?
|
History, 19th Century | 1 | 2017 | 721 | 0.130 |
Why?
|
Pyrimidines | 2 | 2022 | 2918 | 0.130 |
Why?
|
Mitochondria | 3 | 2015 | 3522 | 0.130 |
Why?
|
Gene Silencing | 3 | 2008 | 1537 | 0.120 |
Why?
|
Chromosomes, Human, Pair 3 | 2 | 2010 | 323 | 0.120 |
Why?
|
Transgenes | 1 | 2018 | 1010 | 0.120 |
Why?
|
Quality Control | 1 | 2017 | 842 | 0.120 |
Why?
|
Mice, SCID | 3 | 2018 | 2716 | 0.120 |
Why?
|
Benzimidazoles | 1 | 2019 | 849 | 0.120 |
Why?
|
Acclimatization | 1 | 2014 | 103 | 0.120 |
Why?
|
Acidosis, Lactic | 1 | 2015 | 141 | 0.120 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2000 | 1884 | 0.120 |
Why?
|
GRB10 Adaptor Protein | 1 | 2013 | 22 | 0.120 |
Why?
|
Ribosomal Protein S6 Kinases | 2 | 2004 | 205 | 0.120 |
Why?
|
Gene Targeting | 2 | 2012 | 886 | 0.120 |
Why?
|
Carcinoma | 3 | 2008 | 2361 | 0.120 |
Why?
|
Rats | 12 | 2019 | 24270 | 0.120 |
Why?
|
Brain Neoplasms | 4 | 2023 | 8791 | 0.110 |
Why?
|
Visual Acuity | 1 | 2002 | 2517 | 0.110 |
Why?
|
Mice, Inbred NOD | 2 | 2016 | 1867 | 0.110 |
Why?
|
Angiogenesis Inhibitors | 2 | 2007 | 2037 | 0.110 |
Why?
|
Adenoviruses, Human | 2 | 1997 | 258 | 0.110 |
Why?
|
HCT116 Cells | 1 | 2014 | 409 | 0.110 |
Why?
|
Tamoxifen | 1 | 2018 | 978 | 0.110 |
Why?
|
Glucose Transporter Type 1 | 4 | 2004 | 193 | 0.110 |
Why?
|
Adenocarcinoma | 4 | 2019 | 6318 | 0.110 |
Why?
|
Breast Neoplasms | 4 | 2016 | 20676 | 0.110 |
Why?
|
Immunoprecipitation | 1 | 2015 | 903 | 0.110 |
Why?
|
Pentose Phosphate Pathway | 1 | 2013 | 125 | 0.110 |
Why?
|
DNA Methylation | 3 | 2013 | 4269 | 0.110 |
Why?
|
Genotype | 7 | 2015 | 12951 | 0.110 |
Why?
|
Genes, cdc | 1 | 2012 | 117 | 0.110 |
Why?
|
Blood-Brain Barrier | 1 | 2019 | 1015 | 0.110 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2016 | 476 | 0.110 |
Why?
|
TOR Serine-Threonine Kinases | 4 | 2010 | 2102 | 0.110 |
Why?
|
Retinoblastoma-Like Protein p130 | 2 | 2005 | 76 | 0.110 |
Why?
|
Kidney | 4 | 2009 | 7144 | 0.110 |
Why?
|
Mammary Neoplasms, Experimental | 3 | 1984 | 522 | 0.100 |
Why?
|
Cell Extracts | 2 | 2004 | 138 | 0.100 |
Why?
|
Mixed Function Oxygenases | 2 | 2015 | 272 | 0.100 |
Why?
|
Monosaccharide Transport Proteins | 4 | 2004 | 440 | 0.100 |
Why?
|
Qb-SNARE Proteins | 1 | 2011 | 36 | 0.100 |
Why?
|
Awards and Prizes | 1 | 2016 | 375 | 0.100 |
Why?
|
Adenovirus Early Proteins | 4 | 1992 | 57 | 0.100 |
Why?
|
BRCA1 Protein | 1 | 2018 | 1143 | 0.100 |
Why?
|
Anemia | 2 | 2012 | 1498 | 0.100 |
Why?
|
Female | 30 | 2022 | 378853 | 0.100 |
Why?
|
Chaperonins | 2 | 2002 | 62 | 0.100 |
Why?
|
DNA Replication | 2 | 2008 | 1389 | 0.100 |
Why?
|
Protein Isoforms | 3 | 2020 | 1725 | 0.100 |
Why?
|
Catalysis | 1 | 2013 | 759 | 0.100 |
Why?
|
Adrenal Glands | 2 | 2021 | 545 | 0.100 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2014 | 449 | 0.100 |
Why?
|
Anilides | 1 | 2014 | 405 | 0.100 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2011 | 154 | 0.100 |
Why?
|
Echocardiography | 2 | 2018 | 5098 | 0.100 |
Why?
|
Flow Cytometry | 2 | 2004 | 5959 | 0.100 |
Why?
|
Embryo, Mammalian | 4 | 2007 | 1698 | 0.100 |
Why?
|
DNA Helicases | 1 | 1996 | 843 | 0.100 |
Why?
|
Genes, Reporter | 3 | 2004 | 1549 | 0.100 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2013 | 364 | 0.100 |
Why?
|
Cell Separation | 1 | 1997 | 1739 | 0.100 |
Why?
|
Antioxidants | 1 | 2019 | 1659 | 0.100 |
Why?
|
Platelet-Derived Growth Factor | 2 | 2012 | 625 | 0.100 |
Why?
|
Survival Analysis | 3 | 2016 | 10247 | 0.090 |
Why?
|
beta-Transducin Repeat-Containing Proteins | 1 | 2010 | 32 | 0.090 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 2 | 2019 | 38 | 0.090 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2016 | 3485 | 0.090 |
Why?
|
Casein Kinase I | 1 | 2010 | 46 | 0.090 |
Why?
|
RNA, Neoplasm | 1 | 2013 | 761 | 0.090 |
Why?
|
Deferoxamine | 2 | 2001 | 153 | 0.090 |
Why?
|
Drosophila melanogaster | 1 | 2019 | 1703 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-myc | 3 | 2010 | 984 | 0.090 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 2 | 2006 | 278 | 0.090 |
Why?
|
Isoenzymes | 2 | 2008 | 1720 | 0.090 |
Why?
|
Acetylation | 1 | 2013 | 1085 | 0.090 |
Why?
|
Histone Deacetylases | 2 | 2008 | 729 | 0.090 |
Why?
|
Stomach Neoplasms | 1 | 2019 | 1318 | 0.090 |
Why?
|
Flavoproteins | 1 | 2009 | 44 | 0.090 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2012 | 365 | 0.090 |
Why?
|
Cardiomyopathies | 2 | 2014 | 1911 | 0.090 |
Why?
|
Protein Conformation | 5 | 2002 | 4012 | 0.090 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2013 | 607 | 0.090 |
Why?
|
Electron Transport Complex II | 1 | 2009 | 51 | 0.090 |
Why?
|
Diagnostic Imaging | 1 | 2004 | 3497 | 0.090 |
Why?
|
Spheroids, Cellular | 3 | 2007 | 342 | 0.090 |
Why?
|
Genomics | 4 | 2022 | 5652 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2019 | 1575 | 0.090 |
Why?
|
Neoplasm Metastasis | 3 | 2016 | 4832 | 0.090 |
Why?
|
Polymorphism, Genetic | 1 | 2000 | 4332 | 0.090 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2006 | 1157 | 0.080 |
Why?
|
Blotting, Western | 4 | 2003 | 5181 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 3 | 2006 | 322 | 0.080 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 452 | 0.080 |
Why?
|
Drug Discovery | 1 | 2017 | 1056 | 0.080 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2013 | 666 | 0.080 |
Why?
|
Hematocrit | 1 | 2010 | 636 | 0.080 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2013 | 617 | 0.080 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2409 | 0.080 |
Why?
|
Heart Function Tests | 1 | 2009 | 331 | 0.080 |
Why?
|
Myositis | 1 | 1991 | 248 | 0.080 |
Why?
|
Antibodies, Monoclonal | 2 | 2003 | 9259 | 0.080 |
Why?
|
Codon | 2 | 2000 | 613 | 0.080 |
Why?
|
Models, Molecular | 5 | 2016 | 5460 | 0.080 |
Why?
|
Fatty Acids | 1 | 2016 | 1804 | 0.080 |
Why?
|
Multiprotein Complexes | 4 | 2012 | 1122 | 0.080 |
Why?
|
Inositol 1,4,5-Trisphosphate Receptors | 1 | 2008 | 83 | 0.080 |
Why?
|
Oxidative Phosphorylation | 1 | 2010 | 479 | 0.080 |
Why?
|
Nerve Growth Factor | 2 | 2006 | 148 | 0.080 |
Why?
|
Sequence Alignment | 3 | 2011 | 2256 | 0.080 |
Why?
|
Heart Failure | 2 | 2010 | 10793 | 0.080 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2003 | 2558 | 0.080 |
Why?
|
Oligodeoxyribonucleotides | 4 | 1993 | 708 | 0.080 |
Why?
|
Phosphotransferases | 1 | 2008 | 309 | 0.080 |
Why?
|
Organ Specificity | 3 | 2003 | 2004 | 0.080 |
Why?
|
Myoblasts | 1 | 2008 | 237 | 0.070 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2007 | 1213 | 0.070 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 10999 | 0.070 |
Why?
|
Spodoptera | 1 | 2007 | 151 | 0.070 |
Why?
|
Glutamine | 1 | 2010 | 574 | 0.070 |
Why?
|
Adenoviridae | 2 | 2003 | 1095 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2017 | 2716 | 0.070 |
Why?
|
Ischemia | 1 | 2016 | 1908 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2009 | 4743 | 0.070 |
Why?
|
Anaphase | 1 | 2006 | 120 | 0.070 |
Why?
|
Myocardium | 2 | 2010 | 4788 | 0.070 |
Why?
|
Arginine | 2 | 2000 | 945 | 0.070 |
Why?
|
Chloramphenicol O-Acetyltransferase | 2 | 1997 | 222 | 0.070 |
Why?
|
Cardiomegaly | 1 | 2009 | 620 | 0.070 |
Why?
|
High-Throughput Screening Assays | 1 | 2012 | 953 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2008 | 578 | 0.070 |
Why?
|
Biomedical Research | 1 | 2022 | 3301 | 0.070 |
Why?
|
Animals, Newborn | 2 | 2010 | 2732 | 0.070 |
Why?
|
Renal Insufficiency | 1 | 2012 | 803 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 1997 | 364 | 0.070 |
Why?
|
Mutation, Missense | 3 | 2019 | 2552 | 0.070 |
Why?
|
Periodicals as Topic | 1 | 2017 | 1428 | 0.070 |
Why?
|
Protein Subunits | 1 | 2009 | 964 | 0.070 |
Why?
|
Drosophila Proteins | 1 | 1995 | 1697 | 0.070 |
Why?
|
Technetium Compounds | 1 | 1985 | 15 | 0.070 |
Why?
|
Guanylate Cyclase | 1 | 2006 | 200 | 0.070 |
Why?
|
Male | 17 | 2022 | 349022 | 0.070 |
Why?
|
Antimony | 1 | 1985 | 19 | 0.060 |
Why?
|
Molecular Probe Techniques | 1 | 2005 | 121 | 0.060 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2015 | 3757 | 0.060 |
Why?
|
NIH 3T3 Cells | 1 | 2007 | 677 | 0.060 |
Why?
|
Restriction Mapping | 2 | 1996 | 879 | 0.060 |
Why?
|
Pedigree | 2 | 2011 | 4640 | 0.060 |
Why?
|
Hepatocytes | 2 | 2015 | 1202 | 0.060 |
Why?
|
Mutant Proteins | 1 | 2007 | 500 | 0.060 |
Why?
|
Exons | 5 | 2011 | 2430 | 0.060 |
Why?
|
Chaperonin Containing TCP-1 | 2 | 2002 | 8 | 0.060 |
Why?
|
Lactic Acid | 1 | 2010 | 1132 | 0.060 |
Why?
|
Neurodegenerative Diseases | 1 | 2014 | 1050 | 0.060 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2006 | 281 | 0.060 |
Why?
|
Ascorbic Acid | 1 | 2008 | 649 | 0.060 |
Why?
|
Technetium | 1 | 1985 | 336 | 0.060 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2006 | 180 | 0.060 |
Why?
|
In Situ Nick-End Labeling | 2 | 2003 | 641 | 0.060 |
Why?
|
Cinnarizine | 1 | 1984 | 2 | 0.060 |
Why?
|
Blotting, Far-Western | 1 | 2004 | 4 | 0.060 |
Why?
|
Primary Myelofibrosis | 1 | 1986 | 213 | 0.060 |
Why?
|
Astrocytes | 1 | 2012 | 1258 | 0.060 |
Why?
|
Endopeptidases | 2 | 2006 | 771 | 0.060 |
Why?
|
Amino Acid Motifs | 2 | 2004 | 940 | 0.060 |
Why?
|
Luminescence | 1 | 2005 | 136 | 0.060 |
Why?
|
Genome, Human | 3 | 2013 | 4419 | 0.060 |
Why?
|
Mice, Inbred Strains | 1 | 2007 | 1837 | 0.060 |
Why?
|
Glucose | 2 | 2020 | 4377 | 0.060 |
Why?
|
Phosphoglycerate Kinase | 1 | 2003 | 68 | 0.060 |
Why?
|
Mice, Inbred BALB C | 3 | 2014 | 6397 | 0.060 |
Why?
|
CREB-Binding Protein | 2 | 2000 | 151 | 0.060 |
Why?
|
Phenylalanine | 1 | 2005 | 365 | 0.060 |
Why?
|
Protein Biosynthesis | 4 | 1996 | 2131 | 0.060 |
Why?
|
Immunotherapy | 2 | 2018 | 4391 | 0.060 |
Why?
|
Epidermis | 1 | 2006 | 523 | 0.060 |
Why?
|
Embryo, Nonmammalian | 1 | 2007 | 894 | 0.060 |
Why?
|
Papillomaviridae | 2 | 2000 | 1117 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2013 | 2933 | 0.060 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2011 | 1574 | 0.060 |
Why?
|
Cytoplasm | 3 | 1997 | 1536 | 0.060 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2003 | 135 | 0.060 |
Why?
|
Regional Blood Flow | 3 | 1984 | 1528 | 0.060 |
Why?
|
Neovascularization, Physiologic | 1 | 2010 | 1352 | 0.060 |
Why?
|
Salicylanilides | 1 | 2022 | 15 | 0.060 |
Why?
|
Excitatory Amino Acid Transporter 2 | 1 | 2003 | 77 | 0.060 |
Why?
|
Estrogens | 1 | 2010 | 1561 | 0.060 |
Why?
|
Caspases | 1 | 2006 | 927 | 0.050 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2018 | 888 | 0.050 |
Why?
|
Osteosarcoma | 3 | 1999 | 884 | 0.050 |
Why?
|
Cell Compartmentation | 2 | 1995 | 400 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2019 | 4400 | 0.050 |
Why?
|
Trophoblasts | 2 | 2001 | 214 | 0.050 |
Why?
|
Medulloblastoma | 1 | 2008 | 677 | 0.050 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2023 | 142 | 0.050 |
Why?
|
Adenovirus E1B Proteins | 1 | 2001 | 15 | 0.050 |
Why?
|
Normetanephrine | 1 | 2021 | 26 | 0.050 |
Why?
|
Staphylococcal Infections | 1 | 1991 | 1403 | 0.050 |
Why?
|
Drug Stability | 1 | 2002 | 292 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2012 | 5058 | 0.050 |
Why?
|
Technology, Pharmaceutical | 1 | 2002 | 85 | 0.050 |
Why?
|
Verapamil | 1 | 1982 | 244 | 0.050 |
Why?
|
Inflammation | 3 | 2023 | 10534 | 0.050 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2002 | 192 | 0.050 |
Why?
|
Cell Transplantation | 1 | 2004 | 478 | 0.050 |
Why?
|
Histone Acetyltransferases | 2 | 2000 | 336 | 0.050 |
Why?
|
Retinoblastoma-Like Protein p107 | 2 | 2000 | 74 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 1992 | 2901 | 0.050 |
Why?
|
Cycloheximide | 1 | 2002 | 347 | 0.050 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 1674 | 0.050 |
Why?
|
Fluorescent Antibody Technique | 3 | 1999 | 2503 | 0.050 |
Why?
|
Sequence Deletion | 3 | 1999 | 1528 | 0.050 |
Why?
|
Reticulocytes | 1 | 2002 | 290 | 0.050 |
Why?
|
Helminth Proteins | 1 | 2002 | 171 | 0.050 |
Why?
|
United States | 3 | 2017 | 69573 | 0.050 |
Why?
|
Kinetics | 3 | 1998 | 6475 | 0.050 |
Why?
|
Fluorescence | 1 | 2004 | 751 | 0.050 |
Why?
|
Serine | 1 | 2005 | 831 | 0.050 |
Why?
|
Organ Size | 1 | 2006 | 2247 | 0.050 |
Why?
|
Contrast Sensitivity | 1 | 2002 | 244 | 0.050 |
Why?
|
bcl-X Protein | 1 | 2022 | 413 | 0.050 |
Why?
|
Chromogranins | 1 | 2021 | 162 | 0.050 |
Why?
|
Breast | 1 | 2010 | 1950 | 0.050 |
Why?
|
Cobalt | 1 | 2001 | 159 | 0.050 |
Why?
|
Tomography, Emission-Computed | 1 | 2004 | 1144 | 0.050 |
Why?
|
Albumins | 1 | 2003 | 563 | 0.050 |
Why?
|
Nocodazole | 1 | 2020 | 97 | 0.050 |
Why?
|
Cell Line, Transformed | 2 | 1999 | 897 | 0.050 |
Why?
|
Calcium Channel Blockers | 1 | 1984 | 686 | 0.050 |
Why?
|
Blood Vessels | 1 | 2006 | 1126 | 0.050 |
Why?
|
Micronucleus Tests | 1 | 2019 | 23 | 0.050 |
Why?
|
Hydroxamic Acids | 1 | 2003 | 495 | 0.050 |
Why?
|
Protein Kinase C | 2 | 2005 | 1223 | 0.050 |
Why?
|
Transcription Factor TFIID | 1 | 2000 | 151 | 0.050 |
Why?
|
Neurons | 4 | 2008 | 9336 | 0.050 |
Why?
|
Polymerase Chain Reaction | 4 | 1999 | 6174 | 0.050 |
Why?
|
Molecular Weight | 2 | 2001 | 2257 | 0.050 |
Why?
|
TATA-Binding Protein Associated Factors | 1 | 2000 | 104 | 0.050 |
Why?
|
Xenopus laevis | 1 | 2004 | 953 | 0.040 |
Why?
|
MicroRNAs | 2 | 2013 | 3712 | 0.040 |
Why?
|
Chemokine CXCL9 | 1 | 2019 | 129 | 0.040 |
Why?
|
Two-Hybrid System Techniques | 1 | 2000 | 464 | 0.040 |
Why?
|
Iron | 1 | 2008 | 1776 | 0.040 |
Why?
|
Doxycycline | 1 | 2001 | 327 | 0.040 |
Why?
|
Buthionine Sulfoximine | 1 | 2019 | 18 | 0.040 |
Why?
|
Acetyltransferases | 1 | 2000 | 236 | 0.040 |
Why?
|
Glutamate-Cysteine Ligase | 1 | 2019 | 25 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2010 | 2833 | 0.040 |
Why?
|
Epidermal Growth Factor | 1 | 2002 | 706 | 0.040 |
Why?
|
Ubiquitinated Proteins | 1 | 2019 | 34 | 0.040 |
Why?
|
Thiocyanates | 1 | 2019 | 70 | 0.040 |
Why?
|
Nitric Oxide | 1 | 2008 | 2121 | 0.040 |
Why?
|
Glutathione Transferase | 2 | 1991 | 591 | 0.040 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2002 | 664 | 0.040 |
Why?
|
Immunoenzyme Techniques | 1 | 2002 | 1801 | 0.040 |
Why?
|
Protein Interaction Mapping | 1 | 2002 | 626 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3863 | 0.040 |
Why?
|
Family | 1 | 2009 | 3141 | 0.040 |
Why?
|
Benzamides | 1 | 2004 | 1374 | 0.040 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 1998 | 103 | 0.040 |
Why?
|
Vulvar Neoplasms | 1 | 2000 | 269 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3922 | 0.040 |
Why?
|
Hepatocyte Growth Factor | 1 | 1999 | 270 | 0.040 |
Why?
|
Fluorescein Angiography | 1 | 2002 | 939 | 0.040 |
Why?
|
Blotting, Northern | 2 | 2000 | 1583 | 0.040 |
Why?
|
Lymphedema | 1 | 1985 | 527 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2010 | 3671 | 0.040 |
Why?
|
Kidney Failure, Chronic | 1 | 2010 | 2546 | 0.040 |
Why?
|
Genetic Engineering | 1 | 2003 | 955 | 0.040 |
Why?
|
Mammary Glands, Human | 1 | 2019 | 200 | 0.040 |
Why?
|
Mammary Glands, Animal | 1 | 2019 | 276 | 0.040 |
Why?
|
Endolymphatic Sac | 1 | 1997 | 50 | 0.040 |
Why?
|
Ear Neoplasms | 1 | 1997 | 117 | 0.040 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2004 | 2455 | 0.040 |
Why?
|
Uterus | 2 | 2001 | 712 | 0.040 |
Why?
|
RNA Polymerase I | 1 | 1996 | 24 | 0.040 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1991 | 3323 | 0.040 |
Why?
|
Structural Homology, Protein | 1 | 2016 | 92 | 0.040 |
Why?
|
Triazoles | 1 | 2022 | 906 | 0.040 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 1997 | 224 | 0.040 |
Why?
|
Cisplatin | 2 | 2019 | 1617 | 0.040 |
Why?
|
Catalytic Domain | 1 | 2019 | 698 | 0.040 |
Why?
|
Seeds | 1 | 1996 | 105 | 0.040 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 1996 | 133 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 2 | 2005 | 2748 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 803 | 0.030 |
Why?
|
Gastric Mucosa | 1 | 2019 | 596 | 0.030 |
Why?
|
Adult | 10 | 2023 | 213394 | 0.030 |
Why?
|
Binding, Competitive | 2 | 2000 | 1158 | 0.030 |
Why?
|
Kidney Diseases, Cystic | 1 | 1997 | 185 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2014 | 3615 | 0.030 |
Why?
|
Indicators and Reagents | 1 | 1997 | 460 | 0.030 |
Why?
|
Sirolimus | 1 | 2003 | 1559 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1675 | 0.030 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2002 | 848 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 1431 | 0.030 |
Why?
|
Visual Fields | 1 | 2002 | 1049 | 0.030 |
Why?
|
Body Weight | 1 | 2006 | 4660 | 0.030 |
Why?
|
Genetic Vectors | 2 | 1997 | 3419 | 0.030 |
Why?
|
Syndrome | 1 | 2021 | 3241 | 0.030 |
Why?
|
Peptide Mapping | 1 | 1995 | 263 | 0.030 |
Why?
|
Cytosol | 1 | 1998 | 902 | 0.030 |
Why?
|
Single-Strand Specific DNA and RNA Endonucleases | 1 | 1994 | 31 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2000 | 1280 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 1997 | 657 | 0.030 |
Why?
|
Palliative Care | 1 | 2010 | 3461 | 0.030 |
Why?
|
K562 Cells | 1 | 2016 | 620 | 0.030 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 1985 | 1373 | 0.030 |
Why?
|
Chromosome Disorders | 1 | 1997 | 516 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2000 | 4014 | 0.030 |
Why?
|
Lactates | 1 | 2015 | 434 | 0.030 |
Why?
|
Oligonucleotide Probes | 1 | 1995 | 425 | 0.030 |
Why?
|
Blood Gas Analysis | 1 | 2015 | 380 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2002 | 1066 | 0.030 |
Why?
|
Immune System | 1 | 2019 | 801 | 0.030 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1986 | 2091 | 0.030 |
Why?
|
Introns | 1 | 1996 | 992 | 0.030 |
Why?
|
Pancreatic Cyst | 1 | 1997 | 368 | 0.030 |
Why?
|
RNA | 1 | 2003 | 2723 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 2913 | 0.030 |
Why?
|
Gene Library | 1 | 1996 | 1077 | 0.030 |
Why?
|
Testis | 1 | 1997 | 799 | 0.030 |
Why?
|
Oligopeptides | 1 | 1999 | 1179 | 0.030 |
Why?
|
Altitude | 1 | 2014 | 160 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2021 | 35326 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2015 | 8977 | 0.030 |
Why?
|
Organoids | 1 | 2019 | 687 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2003 | 6871 | 0.030 |
Why?
|
Astrocytoma | 1 | 1997 | 789 | 0.030 |
Why?
|
Tissue Distribution | 1 | 1997 | 2345 | 0.030 |
Why?
|
Tetrahydrofolate Dehydrogenase | 1 | 1993 | 143 | 0.030 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2018 | 721 | 0.030 |
Why?
|
Cerebellar Neoplasms | 1 | 1997 | 582 | 0.030 |
Why?
|
Protein Stability | 1 | 2014 | 554 | 0.030 |
Why?
|
U937 Cells | 1 | 2012 | 267 | 0.030 |
Why?
|
RNA Polymerase II | 1 | 1996 | 551 | 0.030 |
Why?
|
Epithelium | 1 | 1997 | 1684 | 0.030 |
Why?
|
Yersinia Infections | 1 | 1991 | 9 | 0.030 |
Why?
|
Yersinia enterocolitica | 1 | 1991 | 13 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2019 | 1522 | 0.030 |
Why?
|
Recovery of Function | 1 | 2002 | 2924 | 0.030 |
Why?
|
Muscles | 1 | 1997 | 1608 | 0.030 |
Why?
|
Cytokines | 1 | 2007 | 7298 | 0.030 |
Why?
|
Rats, Inbred Strains | 2 | 1984 | 2198 | 0.030 |
Why?
|
Molecular Dynamics Simulation | 1 | 2014 | 409 | 0.030 |
Why?
|
Physical Conditioning, Animal | 1 | 2015 | 360 | 0.030 |
Why?
|
Algorithms | 1 | 2012 | 13872 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2007 | 7897 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 1999 | 1584 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2011 | 4791 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2011 | 6726 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2000 | 2517 | 0.020 |
Why?
|
T-Lymphocytes | 3 | 2000 | 10142 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2019 | 3193 | 0.020 |
Why?
|
Proteomics | 1 | 2004 | 3584 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 1997 | 1812 | 0.020 |
Why?
|
Urinary Bladder | 1 | 1997 | 1153 | 0.020 |
Why?
|
Hydrogen Bonding | 2 | 2002 | 294 | 0.020 |
Why?
|
Chromatography, Affinity | 1 | 1991 | 550 | 0.020 |
Why?
|
Streptococcus agalactiae | 1 | 1991 | 373 | 0.020 |
Why?
|
Organic Cation Transport Proteins | 1 | 2009 | 52 | 0.020 |
Why?
|
DNA, Viral | 1 | 1996 | 2223 | 0.020 |
Why?
|
Cell Nucleus | 1 | 1998 | 2965 | 0.020 |
Why?
|
Pyrazoles | 1 | 2019 | 1963 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2004 | 12948 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2014 | 15500 | 0.020 |
Why?
|
Sin3 Histone Deacetylase and Corepressor Complex | 1 | 2008 | 19 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2011 | 316 | 0.020 |
Why?
|
Streptococcus pyogenes | 1 | 1991 | 289 | 0.020 |
Why?
|
Genes, Viral | 1 | 1990 | 719 | 0.020 |
Why?
|
Colon | 1 | 1997 | 1771 | 0.020 |
Why?
|
Prostate | 1 | 1997 | 1743 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 3 | 2010 | 8299 | 0.020 |
Why?
|
Child | 3 | 2010 | 77033 | 0.020 |
Why?
|
Genetic Variation | 1 | 2003 | 6539 | 0.020 |
Why?
|
Lysine | 1 | 2012 | 1005 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 1996 | 1997 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2009 | 496 | 0.020 |
Why?
|
Oligonucleotides | 1 | 1991 | 572 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2014 | 62693 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1991 | 782 | 0.020 |
Why?
|
Protein Structure, Secondary | 2 | 2002 | 1245 | 0.020 |
Why?
|
Microscopy, Confocal | 2 | 2004 | 1967 | 0.020 |
Why?
|
Streptococcal Infections | 1 | 1991 | 635 | 0.020 |
Why?
|
Neoplasm Invasiveness | 2 | 2009 | 3603 | 0.020 |
Why?
|
Protein Folding | 2 | 2002 | 842 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4374 | 0.020 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2008 | 338 | 0.020 |
Why?
|
Middle Aged | 6 | 2014 | 212863 | 0.020 |
Why?
|
Endothelium | 1 | 2009 | 776 | 0.020 |
Why?
|
Mesoderm | 1 | 2009 | 683 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4424 | 0.020 |
Why?
|
beta Catenin | 1 | 2011 | 1057 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2011 | 1178 | 0.020 |
Why?
|
Epigenomics | 1 | 2011 | 877 | 0.020 |
Why?
|
Crystallography, X-Ray | 2 | 2002 | 2015 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 1990 | 1402 | 0.020 |
Why?
|
Gallium | 1 | 1985 | 29 | 0.020 |
Why?
|
Adolescent | 3 | 2021 | 85405 | 0.020 |
Why?
|
Embryonic Stem Cells | 1 | 2012 | 1294 | 0.020 |
Why?
|
Colloids | 1 | 1985 | 136 | 0.020 |
Why?
|
Cricetinae | 2 | 2001 | 2468 | 0.020 |
Why?
|
Brain | 3 | 2015 | 26345 | 0.020 |
Why?
|
Flunarizine | 1 | 1984 | 7 | 0.020 |
Why?
|
Risk Factors | 2 | 2007 | 71974 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2004 | 301 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2016 | 3508 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2005 | 220 | 0.010 |
Why?
|
Radioisotopes | 1 | 1985 | 502 | 0.010 |
Why?
|
cdc42 GTP-Binding Protein, Saccharomyces cerevisiae | 1 | 2002 | 9 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 1997 | 11347 | 0.010 |
Why?
|
Staphylococcus aureus | 1 | 1991 | 1449 | 0.010 |
Why?
|
Vascular Resistance | 2 | 1983 | 943 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 1996 | 3866 | 0.010 |
Why?
|
Sympathetic Nervous System | 1 | 2005 | 514 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 1995 | 2521 | 0.010 |
Why?
|
Microwaves | 1 | 1983 | 188 | 0.010 |
Why?
|
Gene Frequency | 1 | 2009 | 3585 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4035 | 0.010 |
Why?
|
Cadherins | 1 | 2006 | 901 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2009 | 1662 | 0.010 |
Why?
|
Child, Preschool | 2 | 2010 | 40802 | 0.010 |
Why?
|
Arm | 1 | 1985 | 585 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2694 | 0.010 |
Why?
|
Young Adult | 3 | 2014 | 56255 | 0.010 |
Why?
|
Genome, Fungal | 1 | 2002 | 205 | 0.010 |
Why?
|
Sepsis | 1 | 2015 | 2571 | 0.010 |
Why?
|
E2F2 Transcription Factor | 1 | 2000 | 38 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 10961 | 0.010 |
Why?
|
TATA Box | 1 | 2000 | 128 | 0.010 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2002 | 408 | 0.010 |
Why?
|
Blood Glucose | 1 | 2015 | 6237 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1985 | 2028 | 0.010 |
Why?
|
Gene Products, tat | 1 | 2000 | 120 | 0.010 |
Why?
|
Databases, Protein | 1 | 2002 | 382 | 0.010 |
Why?
|
Heart | 1 | 2014 | 4466 | 0.010 |
Why?
|
E1A-Associated p300 Protein | 1 | 2000 | 131 | 0.010 |
Why?
|
Hyperthermia, Induced | 1 | 1983 | 400 | 0.010 |
Why?
|
Cardiac Output | 1 | 1982 | 857 | 0.010 |
Why?
|
Forecasting | 1 | 2009 | 2952 | 0.010 |
Why?
|
Cystadenoma, Papillary | 1 | 1999 | 7 | 0.010 |
Why?
|
Hydroxyquinolines | 1 | 1999 | 19 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 1999 | 55 | 0.010 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 1999 | 68 | 0.010 |
Why?
|
Base Pair Mismatch | 1 | 1999 | 97 | 0.010 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 1999 | 149 | 0.010 |
Why?
|
Jurkat Cells | 1 | 2000 | 740 | 0.010 |
Why?
|
CHO Cells | 1 | 2001 | 1404 | 0.010 |
Why?
|
Ankyrins | 1 | 1998 | 128 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 1986 | 1170 | 0.010 |
Why?
|
Loss of Heterozygosity | 1 | 2000 | 678 | 0.010 |
Why?
|
Consensus Sequence | 1 | 1998 | 378 | 0.010 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 1998 | 174 | 0.010 |
Why?
|
Extracellular Space | 1 | 1999 | 594 | 0.010 |
Why?
|
Prognosis | 2 | 2009 | 28901 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12761 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 1997 | 572 | 0.010 |
Why?
|
Bone Marrow | 1 | 1986 | 2933 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2002 | 3146 | 0.010 |
Why?
|
Surface Properties | 1 | 1999 | 1181 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 1984 | 2897 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2004 | 2381 | 0.010 |
Why?
|
Genes, ras | 1 | 1998 | 693 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 1996 | 251 | 0.010 |
Why?
|
Janus Kinase 2 | 1 | 1998 | 527 | 0.010 |
Why?
|
Feedback | 1 | 1999 | 788 | 0.010 |
Why?
|
Temperature | 1 | 2001 | 2202 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2000 | 1082 | 0.010 |
Why?
|
Cohort Studies | 1 | 2018 | 40389 | 0.010 |
Why?
|
Fungal Proteins | 1 | 1999 | 910 | 0.010 |
Why?
|
Chimera | 1 | 1996 | 488 | 0.010 |
Why?
|
Endoplasmic Reticulum | 1 | 2000 | 1141 | 0.010 |
Why?
|
Genome | 1 | 2002 | 1794 | 0.010 |
Why?
|
Gene Expression | 2 | 1999 | 7788 | 0.010 |
Why?
|
Hemangioma | 1 | 1999 | 738 | 0.010 |
Why?
|
Precipitin Tests | 1 | 1994 | 829 | 0.010 |
Why?
|
Aged | 2 | 2014 | 162698 | 0.010 |
Why?
|
ras Proteins | 1 | 1998 | 1062 | 0.010 |
Why?
|
Nephrectomy | 1 | 1999 | 1033 | 0.010 |
Why?
|
Lymph Nodes | 1 | 1985 | 3454 | 0.010 |
Why?
|
Culture Media, Serum-Free | 1 | 1993 | 158 | 0.010 |
Why?
|
Serum Response Factor | 1 | 1993 | 81 | 0.010 |
Why?
|
Proteome | 1 | 2002 | 1772 | 0.010 |
Why?
|
Gentamicins | 1 | 1993 | 253 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 38942 | 0.010 |
Why?
|
Cell Count | 1 | 1996 | 1833 | 0.010 |
Why?
|
Up-Regulation | 1 | 2001 | 4205 | 0.010 |
Why?
|
Hematologic Tests | 1 | 1952 | 237 | 0.010 |
Why?
|
Thymus Gland | 1 | 1996 | 1263 | 0.010 |
Why?
|
Heart Rate | 1 | 1982 | 4095 | 0.010 |
Why?
|
Eye Neoplasms | 1 | 1993 | 314 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2009 | 12178 | 0.010 |
Why?
|
DNA Repair | 1 | 1999 | 2030 | 0.010 |
Why?
|
Radiosurgery | 1 | 1999 | 1305 | 0.010 |
Why?
|
Pilot Projects | 1 | 2002 | 8275 | 0.010 |
Why?
|
Capillaries | 1 | 1952 | 767 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 1996 | 1778 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 1991 | 20055 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 1991 | 11699 | 0.000 |
Why?
|
Early Diagnosis | 1 | 1952 | 1186 | 0.000 |
Why?
|
Blood Pressure | 1 | 1982 | 8554 | 0.000 |
Why?
|
Genetic Testing | 1 | 1999 | 3441 | 0.000 |
Why?
|
Cardiovascular System | 1 | 1952 | 830 | 0.000 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1996 | 2185 | 0.000 |
Why?
|
Lymphocyte Activation | 1 | 1993 | 5522 | 0.000 |
Why?
|
Pancreatic Neoplasms | 1 | 1999 | 5213 | 0.000 |
Why?
|
Pregnancy | 1 | 2001 | 29002 | 0.000 |
Why?
|
Age Factors | 1 | 1996 | 18349 | 0.000 |
Why?
|
Time Factors | 1 | 2000 | 40050 | 0.000 |
Why?
|
Early Detection of Cancer | 1 | 1952 | 3051 | 0.000 |
Why?
|